Kurt Anker Nielsen
Founder en Partisia Blockchain Foundation .
Perfil
Kurt Anker Nielsen founded Sepior ApS in 2013, where he worked as Director and Partisia Blockchain Foundation in 1987, where he is working as President from 1987.
Mr. Nielsen also currently works at Collstrups Mindelegat, as Chairman.
Mr. Nielsen also formerly worked at Novo Nordisk A, as Chief Financial Officer & Deputy CEO in 2000, Novo Holdings AS (Denmark), as Co-Chief Executive Officer in 2003, Novozymes A, as Deputy Vice Chairman from 2010 to 2011, Scandinavian Investment Group A, as Chairman-Supervisory Board, Reliance A, as Chairman, Norsk Hydro ASA, as Director, ZymoGenetics, Inc., as Director, Equinor ASA, as Director from 2007 to 2009, Veloxis Pharmaceuticals A, as Independent Director from 2006 to 2013, Vestas Wind Systems A, as Director from 2006 to 2011, Novo Nordisk Fonden, as Director, Dako Denmark ApS, as Director, Carlsberg A, as Business Economist in 1973, and Novo Industri A, as Vice President-Corporate Finance in 1989.
Mr. Nielsen received his graduate degree in 1972 from Copenhagen Business School.
Cargos activos de Kurt Anker Nielsen
| Empresas | Cargo | Inicio |
|---|---|---|
| Collstrups Mindelegat | Chairman | 24/05/2010 |
Partisia Blockchain Foundation
 Partisia Blockchain Foundation Packaged SoftwareTechnology Services Partisia Blockchain Foundation provides blockchain technology services. The company is based in Zug, Switzerland. The Swiss company was founded in 1987 by Peter Frands Frandsen, Kurt Anker Nielsen, Brian Gallagher. | Founder | 01/01/1987 |
Antiguos cargos conocidos de Kurt Anker Nielsen.
| Empresas | Cargo | Fin |
|---|---|---|
| VELOXIS PHARMACEUTICALS A/S | Director/Board Member | 19/04/2013 |
| NOVO NORDISK A/S | Director of Finance/CFO | 01/06/2011 |
| VESTAS WIND SYSTEMS A/S | Director/Board Member | - |
| EQUINOR ASA | Director/Board Member | 25/03/2009 |
Novo Holdings AS (Denmark)
 Novo Holdings AS (Denmark) MiscellaneousMiscellaneous Novo Holding A/S provides financial investments and manages the Novo Nordisk Foundation?s assets. It offers seed and venture capital to development stage companies and takes ownership positions in companies within life science and biotechnology. The company was founded on September 8, 1999 and is headquartered in Hellerup, Denmark. | President | 01/01/2003 |
Formación de Kurt Anker Nielsen.
| Copenhagen Business School | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 6 |
|---|---|
| NORSK HYDRO ASA | Non-Energy Minerals |
| NOVO NORDISK A/S | Health Technology |
| EQUINOR ASA | Energy Minerals |
| VESTAS WIND SYSTEMS A/S | Producer Manufacturing |
| CARLSBERG A/S | Consumer Non-Durables |
| SCANDINAVIAN INVESTMENT GROUP A/S | Finance |
| Empresas privadas | 11 |
|---|---|
ZymoGenetics, Inc.
 ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | Health Technology |
Novozymes A/S
 Novozymes A/S Chemicals: SpecialtyProcess Industries Novozymes A/S engages in the research and development of biotechnology solutions, which produces industrial enzymes and microorganisms. Its business areas include agriculture, bioenergy, biopharma, food and beverage, household care, leather, pulp and paper, textile and wastewater solutions. The company was founded in 2000 and is headquartered in Copenhagen, Denmark. | Process Industries |
Veloxis Pharmaceuticals A/S
 Veloxis Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Veloxis Pharmaceuticals A/S is a commercial-stage specialty pharmaceutical company, which engages in the development and commercialization of medicine for the prevention of organ rejection in kidney transplant patients. The company is focused on the direct commercialization of Envarsus XR in the US, expansion of partnerships for markets, and acquisition of assets utilized in transplant patients and by adjacent medical specialties. Veloxis Pharmaceuticals was founded in June 2002 and is headquartered in Copenhagen, Denmark. | Health Technology |
Novo Nordisk Fonden
 Novo Nordisk Fonden Investment Trusts/Mutual FundsMiscellaneous Novo Nordisk Fonden provides basis for the commercial and research activities conducted by the companies. It also supports scientific and humanitarian purposes activities. It awards grants for research within biomedicine, biotechnology, general practice and family medicine, nursing, and art history at public research institutions. It bridges gap between the discoveries made by researchers in biomedicine and biotechnology and their commercial application. The company was founded by August Krogh, Marie Krogh, Harald Pedersen, Hans Christian Hagedorn, August Kongsted and Thorvald Pedersen in 1922 and is headquartered in Hellerup, Denmark. | Miscellaneous |
Novo Holdings AS (Denmark)
Novo Holdings AS (Denmark) MiscellaneousMiscellaneous Novo Holding A/S provides financial investments and manages the Novo Nordisk Foundation?s assets. It offers seed and venture capital to development stage companies and takes ownership positions in companies within life science and biotechnology. The company was founded on September 8, 1999 and is headquartered in Hellerup, Denmark. | Miscellaneous |
Dako Denmark ApS
 Dako Denmark ApS Medical SpecialtiesHealth Technology Dako Denmark A/S designs and manufactures cancer diagnostic systems. It produces reagents, antibodies, instruments, and software solutions to make diagnoses and determine treatments for patients suffering from cancer. The firm's product areas encompass Immunohistochemistry, pharmacoDiagnostics, molecular pathology, Hematoxylin and Eosin stain, special stains, flow Cytometry, and specific proteins. The company was founded by Niels Harboe in 1966 and is headquartered in Glostrup, Denmark. | Health Technology |
Reliance A/S
 Reliance A/S Miscellaneous Commercial ServicesCommercial Services Reliance A/S provides business consulting services. The company also provides services to the public and initial public offering companies. It offers advices in the areas such as investor relations, corporate finance, equity research, communication and operational and strategic issues. Reliance is headquartered in Copenhagen, Denmark. | Commercial Services |
| Novo Industri A/S | Health Technology |
| Collstrups Mindelegat | |
Sepior ApS
 Sepior ApS Packaged SoftwareTechnology Services Sepior ApS develops cloud-based solutions. It enables organizations to encrypt data going into cloud solutions. The firm offers solutions in the form of a cloud-based key-management. Its security solution builds upon cryptography approach known as multi-party computation. The company was founded by Nicolaj Hojer Nielsen, Ivan Bjerre Damg?rd, Jakob I Pagter, Kurt Nielsen, Thomas Pelle Jakobsen and Jesper Buus Nielsen in 2013 and is headquartered in Copenhagen, Denmark. | Technology Services |
Partisia Blockchain Foundation
Partisia Blockchain Foundation Packaged SoftwareTechnology Services Partisia Blockchain Foundation provides blockchain technology services. The company is based in Zug, Switzerland. The Swiss company was founded in 1987 by Peter Frands Frandsen, Kurt Anker Nielsen, Brian Gallagher. | Technology Services |
- Bolsa de valores
- Insiders
- Kurt Anker Nielsen
